Perth-based regenerative medicine company Orthocell created the procedure, known as Ortho-ATI.
First, it is a small tendon biopsy taken from a healthy area and transferred to a laboratory.
There, the tendon’s stem cells are nourished, growing from thousands of cells to millions.
They are then injected into the injury site, allowing new, healthy tendons to rebuild.
“It’s a minimally invasive approach to healing chronic tendon injuries,” said Orthocell CEO Paul Anderson.
The cells can be stored in the laboratory for up to 20 years and used for future injuries.
Currently, the treatment is only available to patients in clinical trials and is pending approval by the Therapeutic Goods Administration.
West Coast Eagles player Mark LeCras is one of the patients who received the treatment.
The AFL star nearly lost his career after a nasty knee tendon injury that plagued him for 12 months.
“We’ve tried a few different therapies to try and fix it, but we haven’t really done it,” LeCras said. “It completely healed me.”
He has since played eight more seasons which even included a Premiership victory.